Up-to-date information on protocols, safety, and regulations to help you deliver advanced patient care.
This guide provides California clinics with a clear, step-by-step pathway to comply with state and federal regulations for biologics, focusing on stem cell therapies. From FDA guidelines to patient consent and provider qualifications, each section aims to empower practitioners with the knowledge needed to confidently offer compliant biologics treatments.
The U.S. Food and Drug Administration (FDA) regulates human cells, tissues, and cellular- and tissue-based products (HCT/Ps) under Section 361 of the Public Health Service Act and 21 CFR Part 1271. California providers must adhere to these federal guidelines, which detail requirements on sourcing, processing, and labeling of biologic materials, as well as how and when Investigational New Drug (IND) applications may be required.
California State Regulations
California enforces additional regulations through the California Department of Public Health (CDPH), with oversight on biologics that may involve stem cell and tissue-based therapies. Clinics are encouraged to review state-specific guidelines for stem cell treatments to ensure compliance with local standards, including patient safety and ethical administration practices.
Only licensed medical doctors (MDs) and doctors of osteopathic medicine (DOs) in California are permitted to administer stem cell therapies. To learn more about licensure requirements, visit the Medical Board of California. Nurse practitioners and physician assistants may support in administering these treatments under direct supervision of a licensed physician.
Patient Informed Consent
Key Consent Elements
California requires explicit patient consent that covers the experimental nature of biologics and potential risks. A compliant informed consent form should include:
A detailed explanation of the procedure, including risks and benefits.
Notification of the experimental or investigational nature of certain treatments, as biologics may not be FDA-approved for certain uses.
Patient rights to discontinue treatment at any time without penalty.
Additional Compliance Steps
Pre-treatment and Post-treatment Protocols
Clinics should establish clear pre-treatment and post-treatment protocols, focusing on patient eligibility, follow-up visits, and outcome monitoring to ensure safety and regulatory compliance.
Standard Operating Procedures (SOPs)
Documented SOPs are essential for compliant administration, storage, and handling of biologic materials. They ensure consistency and adherence to both federal and state regulations.
Medical Liability Insurance
Clinics are encouraged to obtain adequate medical liability insurance that covers biologics and stem cell treatments to mitigate potential legal risks.
Marketing Compliance
Advertising for biologic treatments in California must adhere to FDA marketing regulations and cannot mislead patients regarding the efficacy or safety of treatments. Consult the FDA’s guidance on healthcare advertising to ensure all marketing efforts are compliant.
This guide is provided as an informational resource to help clinics and practitioners understand general compliance requirements for biologics in California. It is not intended to serve as legal advice or replace consultation with qualified legal professionals. Regulations may vary and are subject to change; clinics and practitioners should consult legal counsel or regulatory experts for advice specific to their circumstances and ensure full compliance with all applicable federal and state laws. The authors and publishers of this guide disclaim any liability arising from its use or reliance on the information provided.
The purpose of this website is to provide information for on protocols and general information about biologics, including the regulations and basic information.
The purpose of this website is to provide information for on protocols and general information about biologics, including the regulations and basic information.
About
Our mission is to equip practitioners with essential knowledge on biologics, covering protocols, regulatory guidelines, and foundational insights. This site serves as a trusted resource for navigating the evolving landscape of stem cell applications in clinical practice.
Disclaimer
The information on this website is provided solely for informational purposes and has not been reviewed or approved by the FDA or any other regulatory authority. It does not constitute medical advice, diagnosis, treatment, or any guarantees of medical outcomes and should not be used as a substitute for formal medical education and training, nor as a substitute for consultation with qualified healthcare professionals. Similarly, the content does not provide legal advice or guidance on regulatory compliance and should not replace consultations with qualified legal professionals.
DiscoverBiologics.com makes no representations or warranties, express or implied, regarding the accuracy, reliability, or applicability of the information provided to individual health circumstances or the legal use and adoption of biological products by clinics or providers.
By accessing this website, you agree to the terms and conditions outlined herein and accept full responsibility for compliance and clinical decisions made within your practice. You also acknowledge that you have been encouraged to review the disclaimer page and understand that any reliance on the information provided is voluntary and at your own risk and sole discretion.
2025 © All Rights Reserved. DiscoverBiologics.com